- United States
- /
- Life Sciences
- /
- NYSE:A
Agilent Technologies Full Year 2024 Earnings: In Line With Expectations
Agilent Technologies (NYSE:A) Full Year 2024 Results
Key Financial Results
- Revenue: US$6.51b (down 4.7% from FY 2023).
- Net income: US$1.29b (up 4.0% from FY 2023).
- Profit margin: 20% (up from 18% in FY 2023). The increase in margin was driven by lower expenses.
- EPS: US$4.45 (up from US$4.22 in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Agilent Technologies Meets Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) was also in line with analyst expectations.
The primary driver behind last 12 months revenue was the Life Sciences and Applied Markets Group segment contributing a total revenue of US$3.22b (49% of total revenue). The largest operating expense was General & Administrative costs, amounting to US$1.50b (67% of total expenses). Explore how A's revenue and expenses shape its earnings.
Looking ahead, revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 6.2% growth forecast for the Life Sciences industry in the US.
Performance of the American Life Sciences industry.
The company's shares are down 2.3% from a week ago.
Balance Sheet Analysis
While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We've done some analysis and you can see our take on Agilent Technologies' balance sheet.
Mobile Infrastructure for Defense and Disaster
The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.
Get the investor briefing before the next round of contracts
Sponsored On Behalf of CiTechNew: Manage All Your Stock Portfolios in One Place
We've created the ultimate portfolio companion for stock investors, and it's free.
• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:A
Agilent Technologies
Provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
Excellent balance sheet average dividend payer.
Similar Companies
Market Insights
Weekly Picks
Early mover in a fast growing industry. Likely to experience share price volatility as they scale

A case for CA$31.80 (undiluted), aka 8,616% upside from CA$0.37 (an 86 bagger!).

Moderation and Stabilisation: HOLD: Fair Price based on a 4-year Cycle is $12.08
Recently Updated Narratives
Airbnb Stock: Platform Growth in a World of Saturation and Scrutiny
Adobe Stock: AI-Fueled ARR Growth Pushes Guidance Higher, But Cost Pressures Loom
Thomson Reuters Stock: When Legal Intelligence Becomes Mission-Critical Infrastructure
Popular Narratives

Crazy Undervalued 42 Baggers Silver Play (Active & Running Mine)

NVDA: Expanding AI Demand Will Drive Major Data Center Investments Through 2026

The AI Infrastructure Giant Grows Into Its Valuation
Trending Discussion
